-
-
-
-
-
-
-
AbbVie updates 2026 EPS guidance after $291M IPR&D charge
-
-
-
-
-
-
-
AbbVie (ABBV) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY26 EPS Guidance
-
-
-
-
-
-
-
AbbVie (ABBV) Tops Q4 EPS by 6c, Beats on Revenue; Offers FY26 EPS Guidance
-
-
-
-
-
-
-
HSBC lists 11 potential U.S. outperformers heading into earnings
-
-
-
-
-
-
-
AbbVie (ABBV) Tops Q3 EPS by 8c, Beats on Revenue; Offers FY25 EPS Guidance
-
-
-
-
-
-
-
AbbVie to Host Third-Quarter 2025 Earnings Conference Call
-
-
-
-
-
-
-
AbbVie (ABBV) Issues Q2 and FY25 Guidance
-
1,211,523 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

